ROSSET, FRANCOIS
ROSSET, FRANCOIS
SCIENZE MEDICHE
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study
2023-01-01 Rosset, Francois; Mastorino, Luca; Dapavo, Paolo; Ortoncelli, Michela; Quaglino, Pietro; Ribero, Simone
Beyond Staphylococcus: The Cutaneous Microbiome in Itch Pathobiology
2025-01-01 Rosset, Francois; Pala, Valentina; Santaniello, Umberto; Celoria, Valentina; Mastorino, Luca; Goso, Federico; Pucciariello, Andrea; Bongiovanni, Eleonora; Ribero, Simone; Quaglino, Pietro
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study
2023-01-01 Mastorino, Luca; Burzi, Lorenza; Frigatti, Giada; Fazio, Alessandra; Celoria, Valentina; Macagno, Nicole; Rosset, Francois; Passerini, Stefania Ginevra; Roccuzzo, Gabriele; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
2025-01-01 Marino, Marta; Rosset, Francois; Nervo, Alice; Piovesan, Alessandro; Pala, Valentina; Vaccaro, Elisa; Mastorino, Luca; Calogero, Aldo E; Arvat, Emanuela
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years
2024-01-01 Mastorino, L; Dapavo, P; Burzi, L; Rosset, F; Giunipero di Corteranzo, I; Leo, F; Verrone, A; Stroppiana, E; Ortoncelli, M; Ribero, S; Quaglino, P
Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis over up to 3 years
2024-01-01 Mastorino, Luca; Dapavo, Paolo; Burzi, Lorenza; Rosset, Francois; di Giunipero di Corteranzo, Isotta; Leo, Francesco; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Ribero, Simone; Quaglino, Pietro
Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk
2024-01-01 Boskovic, Sara; Borriello, Silvia; D'Ascenzo, Fabrizio; Sciamarrelli, Nadia; Rosset, Francois; Mastorino, Luca; Paolo, Dapavo; Bocchino, Pier Paolo; De Filippo, Ovidio; Ribero, Simone; De Ferrari, Gaetano; Quaglino, Pietro
Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis
2023-01-01 Rosset, F; Mastorino, L; Dapavo, P; Quaglino, P; Ribero, S
Rare scleromyxedema granuloma-annulare-like pattern successfully treated with intravenous immunoglobulins
2024-01-01 BURZI, Lorenza; ROSSET, Francois; SENETTA, Rebecca; CONTI, Luca; MASTORINO, Luca; DAPAVO, Paolo; QUAGLINO, Pietro; RIBERO, Simone
The Skin Microbiome and Its Role in Psoriasis: A Review
2023-01-01 Celoria, Valentina; Rosset, Francois; Pala, Valentina; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro; Mastorino, Luca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study | 2023 | Rosset, Francois; Mastorino, Luca; Dapavo, Paolo; Ortoncelli, Michela; Quaglino, Pietro; Ribero, Simone | |
| Beyond Staphylococcus: The Cutaneous Microbiome in Itch Pathobiology | 2025 | Rosset, Francois; Pala, Valentina; Santaniello, Umberto; Celoria, Valentina; Mastorino, Luca; Goso, Federico; Pucciariello, Andrea; Bongiovanni, Eleonora; Ribero, Simone; Quaglino, Pietro | |
| Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study | 2023 | Mastorino, Luca; Burzi, Lorenza; Frigatti, Giada; Fazio, Alessandra; Celoria, Valentina; Macagno, Nicole; Rosset, Francois; Passerini, Stefania Ginevra; Roccuzzo, Gabriele; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone | |
| Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies | 2025 | Marino, Marta; Rosset, Francois; Nervo, Alice; Piovesan, Alessandro; Pala, Valentina; Vaccaro, Elisa; Mastorino, Luca; Calogero, Aldo E; Arvat, Emanuela | |
| Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years | 2024 | Mastorino, L; Dapavo, P; Burzi, L; Rosset, F; Giunipero di Corteranzo, I; Leo, F; Verrone, A; Stroppiana, E; Ortoncelli, M; Ribero, S; Quaglino, P | |
| Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis over up to 3 years | 2024 | Mastorino, Luca; Dapavo, Paolo; Burzi, Lorenza; Rosset, Francois; di Giunipero di Corteranzo, Isotta; Leo, Francesco; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Ribero, Simone; Quaglino, Pietro | |
| Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk | 2024 | Boskovic, Sara; Borriello, Silvia; D'Ascenzo, Fabrizio; Sciamarrelli, Nadia; Rosset, Francois; Mastorino, Luca; Paolo, Dapavo; Bocchino, Pier Paolo; De Filippo, Ovidio; Ribero, Simone; De Ferrari, Gaetano; Quaglino, Pietro | |
| Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis | 2023 | Rosset, F; Mastorino, L; Dapavo, P; Quaglino, P; Ribero, S | |
| Rare scleromyxedema granuloma-annulare-like pattern successfully treated with intravenous immunoglobulins | 2024 | BURZI, Lorenza; ROSSET, Francois; SENETTA, Rebecca; CONTI, Luca; MASTORINO, Luca; DAPAVO, Paolo; QUAGLINO, Pietro; RIBERO, Simone | |
| The Skin Microbiome and Its Role in Psoriasis: A Review | 2023 | Celoria, Valentina; Rosset, Francois; Pala, Valentina; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro; Mastorino, Luca |